fig.5.c

Belyaeva OV et al. (2012)

Xla Wt + sdr16c5

NF32-32 (in situ hybridization)

Expression Phenotype
decreased amount otx2.S expression in eye primordium decreased amount rax.L expression in eye primordium mislocalised egr2.L expression in presumptive rhombomere mislocalised en2.L expression in midbrain

fig.7.e

Belyaeva OV et al. (2012)

Xla Wt + sdr16c5 MO

NF13-14 (in situ hybridization)

Expression Phenotype
increased amount sox3.S expression in neural plate

fig.7.f

Belyaeva OV et al. (2012)

Xla Wt + sdr16c5 MO

NF14 (in situ hybridization)

Expression Phenotype
decreased amount shh.L expression in notochord increased amount shh.L expression in notochord

fig.7.b

Belyaeva OV et al. (2012)

Xla Wt + sdr16c5 MO

NF18-19 (in situ hybridization)

Expression Phenotype
decreased amount hoxd4.L expression in hindbrain decreased amount hoxd4.L expression in neural fold mislocalised hoxd4.L expression in hindbrain

fig.7.d

Belyaeva OV et al. (2012)

Xla Wt + sdr16c5 MO

NF18-19 (in situ hybridization)

Expression Phenotype
decreased amount hoxd4.L expression in hindbrain decreased amount hoxd4.L expression in neural fold mislocalised hoxd4.L expression in hindbrain

fig.7.a

Belyaeva OV et al. (2012)

Xla Wt + sdr16c5 MO

NF20 (in situ hybridization)

Expression Phenotype
decreased amount egr2.L expression in neural crest decreased amount egr2.L expression in presumptive rhombomere decreased amount otx2.S expression in eye primordium mislocalised egr2.L expression in presumptive rhombomere mislocalised otx2.S expression in eye primordium